Clinical Trial Update: Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 trial evaluating deferoxamine for aneurysmal subarachnoid hemorrhage. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Deferoxamine (deferoxamine)

Snippet

Sponsor: Aditya S. Pandey, MD | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Status: RECRUITING